Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Plausible Mechanism Draft Guidance
-
Stakeholder letter regarding Medicare physician payment provisions in the Senate鈥檚 reconciliation bill
-
Stakeholder Letter Opposing the Patent Eligibility Restoration Act (PERA)
-
Sign-on Letter Urging Passage of the Medicare Patient Access and Practice Stabilization Act
-
Sign-on Letter Urging Passage of the Medicare Patient Access and Practice Stabilization Act
-
ACMG Comments on CMS Proposed Rule for CY 2025 PFS and Other Medicare Changes
-
Stakeholder Letter Supporting Joint Resolutions to Overturn FDA Rule on LDTs
-
ACMG Response to Senate HELP Committee RFI on Diagnostics Regulation
-
Sign-on Letter Opposing the Patent Eligibility Restoraction Act of 2024
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases